Exact Mass: 919.6536984

PC(22:4(7Z,10Z,13Z,16Z)/24:1(15Z))

C54H98NO8P (919.7029678)

PC(22:4(7Z,10Z,13Z,16Z)/24:1(15Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:4(7Z,10Z,13Z,16Z)/24:1(15Z)), in particular, consists of one chain of adrenic acid at the C-1 position and one chain of nervonic acid at the C-2 position. The adrenic acid moiety is derived from animal fats, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(22:5(4Z,7Z,10Z,13Z,16Z)/24:0)

C54H98NO8P (919.7029678)

PC(22:5(4Z,7Z,10Z,13Z,16Z)/24:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:5(4Z,7Z,10Z,13Z,16Z)/24:0), in particular, consists of one chain of docosapentaenoic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. The docosapentaenoic acid moiety is derived from animal fats and brain, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(22:5(4Z,7Z,10Z,13Z,16Z)/24:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:5(4Z,7Z,10Z,13Z,16Z)/24:0), in particular, consists of one chain of docosapentaenoic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. The docosapentaenoic acid moiety is derived from animal fats and brain, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(22:5(7Z,10Z,13Z,16Z,19Z)/24:0)

C54H98NO8P (919.7029678)

PC(22:5(7Z,10Z,13Z,16Z,19Z)/24:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:5(7Z,10Z,13Z,16Z,19Z)/24:0), in particular, consists of one chain of docosapentaenoic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. The docosapentaenoic acid moiety is derived from fish oils, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(24:0/22:5(4Z,7Z,10Z,13Z,16Z))

C54H98NO8P (919.7029678)

PC(24:0/22:5(4Z,7Z,10Z,13Z,16Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(24:0/22:5(4Z,7Z,10Z,13Z,16Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of docosapentaenoic acid at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the docosapentaenoic acid moiety is derived from animal fats and brain. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(24:0/22:5(7Z,10Z,13Z,16Z,19Z))

C54H98NO8P (919.7029678)

PC(24:0/22:5(7Z,10Z,13Z,16Z,19Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(24:0/22:5(7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of docosapentaenoic acid at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the docosapentaenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(24:1(15Z)/22:4(7Z,10Z,13Z,16Z))

C54H98NO8P (919.7029678)

PC(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of adrenic acid at the C-2 position. The nervonic acid moiety is derived from fish oils, while the adrenic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PS(22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))

C52H90NO10P (919.6302009999999)

PS(22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z)) is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. PS(22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z)), in particular, consists of one chain of clupanodonic acid at the C-1 position and one chain of nervonic acid at the C-2 position. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants, and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups (i.e. the phosphate moiety, the amino group and the carboxyl group). As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have a palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.

PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0)

C52H90NO10P (919.6302009999999)

PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0) is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0), in particular, consists of one chain of docosahexaenoic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants, and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups (i.e. the phosphate moiety, the amino group and the carboxyl group). As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have a palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.

PS(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

C52H90NO10P (919.6302009999999)

PS(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. PS(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of docosahexaenoic acid at the C-2 position. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants, and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups (i.e. the phosphate moiety, the amino group and the carboxyl group). As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have a palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.

PS(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))

C52H90NO10P (919.6302009999999)

PS(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)) is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. PS(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of clupanodonic acid at the C-2 position. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants, and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups (i.e. the phosphate moiety, the amino group and the carboxyl group). As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have a palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.

PS(22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))

C52H90NO10P (919.6302009999999)

PS(22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z)) is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PS(22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z)), in particular, consists of one 4Z,7Z,10Z,13Z,16Z-docosapentaenoyl chain to the C-1 atom, and one 15Z-tetracosenoyl to the C-2 atom. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.

PS(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))

C52H90NO10P (919.6302009999999)

PS(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)) is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PS(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)), in particular, consists of one 15Z-tetracosenoyl chain to the C-1 atom, and one 4Z,7Z,10Z,13Z,16Z-docosapentaenoyl to the C-2 atom. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.

PS(22:0/PGF1alpha)

C48H90NO13P (919.6149459999999)

PS(22:0/PGF1alpha) is an oxidized phosphatidylserine (PS). Oxidized phosphatidylserines are glycerophospholipids in which a phosphorylserine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylserines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PS(22:0/PGF1alpha), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of Prostaglandin F1alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PSs can be synthesized via three different routes. In one route, the oxidized PS is synthetized de novo following the same mechanisms as for PSs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PS backbone, mainly through the action of LOX (PMID: 33329396).

PS(PGF1alpha/22:0)

C48H90NO13P (919.6149459999999)

PS(PGF1alpha/22:0) is an oxidized phosphatidylserine (PS). Oxidized phosphatidylserines are glycerophospholipids in which a phosphorylserine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylserines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PS(PGF1alpha/22:0), in particular, consists of one chain of one Prostaglandin F1alpha at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PSs can be synthesized via three different routes. In one route, the oxidized PS is synthetized de novo following the same mechanisms as for PSs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PS backbone, mainly through the action of LOX (PMID: 33329396).

PC(22:1(13Z)/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C52H90NO10P (919.6302009999999)

PC(22:1(13Z)/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:1(13Z)/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)), in particular, consists of one chain of one 13Z-docosenoyl at the C-1 position and one chain of Resolvin D5 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/22:1(13Z))

C52H90NO10P (919.6302009999999)

PC(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/22:1(13Z)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/22:1(13Z)), in particular, consists of one chain of one Resolvin D5 at the C-1 position and one chain of 13Z-docosenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:1(13Z)/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C52H90NO10P (919.6302009999999)

PC(22:1(13Z)/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:1(13Z)/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)), in particular, consists of one chain of one 13Z-docosenoyl at the C-1 position and one chain of Protectin DX at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/22:1(13Z))

C52H90NO10P (919.6302009999999)

PC(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/22:1(13Z)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/22:1(13Z)), in particular, consists of one chain of one Protectin DX at the C-1 position and one chain of 13Z-docosenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(DiMe(13,5)/20:3(5Z,8Z,11Z)-O(14R,15S))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:3(5Z,8Z,11Z)-O(14R,15S)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(DiMe(13,5)/20:3(5Z,8Z,11Z)-O(14R,15S)), in particular, consists of one chain of one 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-1 position and one chain of 14,15-epoxyeicosatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:3(5Z,8Z,11Z)-O(14R,15S)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(20:3(5Z,8Z,11Z)-O(14R,15S)/DiMe(13,5)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:3(5Z,8Z,11Z)-O(14R,15S)/DiMe(13,5)), in particular, consists of one chain of one 14,15-epoxyeicosatrienoyl at the C-1 position and one chain of 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(DiMe(13,5)/20:3(5Z,8Z,14Z)-O(11S,12R))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:3(5Z,8Z,14Z)-O(11S,12R)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(DiMe(13,5)/20:3(5Z,8Z,14Z)-O(11S,12R)), in particular, consists of one chain of one 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-1 position and one chain of 11,12-epoxyeicosatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:3(5Z,8Z,14Z)-O(11S,12R)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(20:3(5Z,8Z,14Z)-O(11S,12R)/DiMe(13,5)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:3(5Z,8Z,14Z)-O(11S,12R)/DiMe(13,5)), in particular, consists of one chain of one 11,12-epoxyeicosatrienoyl at the C-1 position and one chain of 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(DiMe(13,5)/20:3(5Z,11Z,14Z)-O(8,9))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:3(5Z,11Z,14Z)-O(8,9)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(DiMe(13,5)/20:3(5Z,11Z,14Z)-O(8,9)), in particular, consists of one chain of one 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-1 position and one chain of 8,9--epoxyeicosatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:3(5Z,11Z,14Z)-O(8,9)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(20:3(5Z,11Z,14Z)-O(8,9)/DiMe(13,5)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:3(5Z,11Z,14Z)-O(8,9)/DiMe(13,5)), in particular, consists of one chain of one 8,9--epoxyeicosatrienoyl at the C-1 position and one chain of 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(DiMe(13,5)/20:3(8Z,11Z,14Z)-O(5,6))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:3(8Z,11Z,14Z)-O(5,6)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(DiMe(13,5)/20:3(8Z,11Z,14Z)-O(5,6)), in particular, consists of one chain of one 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-1 position and one chain of 5,6-epoxyeicosatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:3(8Z,11Z,14Z)-O(5,6)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(20:3(8Z,11Z,14Z)-O(5,6)/DiMe(13,5)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:3(8Z,11Z,14Z)-O(5,6)/DiMe(13,5)), in particular, consists of one chain of one 5,6-epoxyeicosatrienoyl at the C-1 position and one chain of 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(20))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(20)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(20)), in particular, consists of one chain of one 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-1 position and one chain of 20-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5Z,8Z,11Z,14Z)-OH(20)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(20)/DiMe(13,5)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5Z,8Z,11Z,14Z)-OH(20)/DiMe(13,5)), in particular, consists of one chain of one 20-Hydroxyeicosatetraenoyl at the C-1 position and one chain of 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(DiMe(13,5)/20:4(6E,8Z,11Z,14Z)-OH(5S))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(6E,8Z,11Z,14Z)-OH(5S)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(DiMe(13,5)/20:4(6E,8Z,11Z,14Z)-OH(5S)), in particular, consists of one chain of one 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-1 position and one chain of 5-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(6E,8Z,11Z,14Z)-OH(5S)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(20:4(6E,8Z,11Z,14Z)-OH(5S)/DiMe(13,5)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(6E,8Z,11Z,14Z)-OH(5S)/DiMe(13,5)), in particular, consists of one chain of one 5-Hydroxyeicosatetraenoyl at the C-1 position and one chain of 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(19S)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(19S)), in particular, consists of one chain of one 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-1 position and one chain of 19-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5Z,8Z,11Z,14Z)-OH(19S)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(19S)/DiMe(13,5)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5Z,8Z,11Z,14Z)-OH(19S)/DiMe(13,5)), in particular, consists of one chain of one 19-Hydroxyeicosatetraenoyl at the C-1 position and one chain of 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(18R)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(18R)), in particular, consists of one chain of one 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-1 position and one chain of 18-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5Z,8Z,11Z,14Z)-OH(18R)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(18R)/DiMe(13,5)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5Z,8Z,11Z,14Z)-OH(18R)/DiMe(13,5)), in particular, consists of one chain of one 18-Hydroxyeicosatetraenoyl at the C-1 position and one chain of 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(17))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(17)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(17)), in particular, consists of one chain of one 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-1 position and one chain of 17-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5Z,8Z,11Z,14Z)-OH(17)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(17)/DiMe(13,5)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5Z,8Z,11Z,14Z)-OH(17)/DiMe(13,5)), in particular, consists of one chain of one 17-Hydroxyeicosatetraenoyl at the C-1 position and one chain of 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(16R)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(16R)), in particular, consists of one chain of one 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-1 position and one chain of 16-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5Z,8Z,11Z,14Z)-OH(16R)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(16R)/DiMe(13,5)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5Z,8Z,11Z,14Z)-OH(16R)/DiMe(13,5)), in particular, consists of one chain of one 16-Hydroxyeicosatetraenoyl at the C-1 position and one chain of 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,13E)-OH(15S))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,13E)-OH(15S)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(DiMe(13,5)/20:4(5Z,8Z,11Z,13E)-OH(15S)), in particular, consists of one chain of one 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-1 position and one chain of 15-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5Z,8Z,11Z,13E)-OH(15S)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(20:4(5Z,8Z,11Z,13E)-OH(15S)/DiMe(13,5)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5Z,8Z,11Z,13E)-OH(15S)/DiMe(13,5)), in particular, consists of one chain of one 15-Hydroxyeicosatetraenoyl at the C-1 position and one chain of 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(DiMe(13,5)/20:4(5Z,8Z,10E,14Z)-OH(12S))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5Z,8Z,10E,14Z)-OH(12S)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(DiMe(13,5)/20:4(5Z,8Z,10E,14Z)-OH(12S)), in particular, consists of one chain of one 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-1 position and one chain of 12-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5Z,8Z,10E,14Z)-OH(12S)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(20:4(5Z,8Z,10E,14Z)-OH(12S)/DiMe(13,5)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5Z,8Z,10E,14Z)-OH(12S)/DiMe(13,5)), in particular, consists of one chain of one 12-Hydroxyeicosatetraenoyl at the C-1 position and one chain of 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(DiMe(13,5)/20:4(5E,8Z,12Z,14Z)-OH(11R))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5E,8Z,12Z,14Z)-OH(11R)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(DiMe(13,5)/20:4(5E,8Z,12Z,14Z)-OH(11R)), in particular, consists of one chain of one 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-1 position and one chain of 11-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5E,8Z,12Z,14Z)-OH(11R)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(20:4(5E,8Z,12Z,14Z)-OH(11R)/DiMe(13,5)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5E,8Z,12Z,14Z)-OH(11R)/DiMe(13,5)), in particular, consists of one chain of one 11-Hydroxyeicosatetraenoyl at the C-1 position and one chain of 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(DiMe(13,5)/20:4(5Z,7E,11Z,14Z)-OH(9))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5Z,7E,11Z,14Z)-OH(9)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(DiMe(13,5)/20:4(5Z,7E,11Z,14Z)-OH(9)), in particular, consists of one chain of one 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-1 position and one chain of 9-Hydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:4(5Z,7E,11Z,14Z)-OH(9)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(20:4(5Z,7E,11Z,14Z)-OH(9)/DiMe(13,5)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:4(5Z,7E,11Z,14Z)-OH(9)/DiMe(13,5)), in particular, consists of one chain of one 9-Hydroxyeicosatetraenoyl at the C-1 position and one chain of 14,17-epoxy-15-methyldocosa-14,16-dienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

Lecithin

C54H98NO8P (919.7029678)

Hex2Cer 38:0;O2

C50H97NO13 (919.6959552)

C20 DHLacCer

C50H97NO13 (919.6959552)

PS(22:0/PGF1alpha)

C48H90NO13P (919.6149459999999)

PS(PGF1alpha/22:0)

C48H90NO13P (919.6149459999999)

PC(DiMe(13,5)/20:3(5Z,8Z,11Z)-O(14R,15S))

C52H90NO10P (919.6302009999999)

PC(20:3(5Z,8Z,11Z)-O(14R,15S)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:3(5Z,8Z,14Z)-O(11S,12R))

C52H90NO10P (919.6302009999999)

PC(20:3(5Z,8Z,14Z)-O(11S,12R)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:3(5Z,11Z,14Z)-O(8,9))

C52H90NO10P (919.6302009999999)

PC(20:3(5Z,11Z,14Z)-O(8,9)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:3(8Z,11Z,14Z)-O(5,6))

C52H90NO10P (919.6302009999999)

PC(20:3(8Z,11Z,14Z)-O(5,6)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(20))

C52H90NO10P (919.6302009999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(20)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(6E,8Z,11Z,14Z)-OH(5S))

C52H90NO10P (919.6302009999999)

PC(20:4(6E,8Z,11Z,14Z)-OH(5S)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C52H90NO10P (919.6302009999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(19S)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C52H90NO10P (919.6302009999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(18R)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(17))

C52H90NO10P (919.6302009999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(17)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C52H90NO10P (919.6302009999999)

PC(20:4(5Z,8Z,11Z,14Z)-OH(16R)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5Z,8Z,11Z,13E)-OH(15S))

C52H90NO10P (919.6302009999999)

PC(20:4(5Z,8Z,11Z,13E)-OH(15S)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5Z,8Z,10E,14Z)-OH(12S))

C52H90NO10P (919.6302009999999)

PC(20:4(5Z,8Z,10E,14Z)-OH(12S)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5E,8Z,12Z,14Z)-OH(11R))

C52H90NO10P (919.6302009999999)

PC(20:4(5E,8Z,12Z,14Z)-OH(11R)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(DiMe(13,5)/20:4(5Z,7E,11Z,14Z)-OH(9))

C52H90NO10P (919.6302009999999)

PC(20:4(5Z,7E,11Z,14Z)-OH(9)/DiMe(13,5))

C52H90NO10P (919.6302009999999)

PC(22:1(13Z)/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C52H90NO10P (919.6302009999999)

PC(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/22:1(13Z))

C52H90NO10P (919.6302009999999)

PC(22:1(13Z)/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C52H90NO10P (919.6302009999999)

PC(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/22:1(13Z))

C52H90NO10P (919.6302009999999)

[3-[(Z)-hexacos-15-enoyl]oxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

SHexCer 43:2;3O

C49H93NO12S (919.6418138)

PI-Cer 43:2;3O

C49H94NO12P (919.6513293999999)

HexCer 9:1;2O/42:9

C57H93NO8 (919.6900818)

HexCer 25:3;2O/26:7

C57H93NO8 (919.6900818)

HexCer 9:0;2O/42:10

C57H93NO8 (919.6900818)

HexCer 15:3;2O/36:7

C57H93NO8 (919.6900818)

HexCer 17:1;2O/34:9

C57H93NO8 (919.6900818)

HexCer 11:1;2O/40:9

C57H93NO8 (919.6900818)

HexCer 19:1;2O/32:9

C57H93NO8 (919.6900818)

HexCer 23:3;2O/28:7

C57H93NO8 (919.6900818)

HexCer 13:2;2O/38:8

C57H93NO8 (919.6900818)

HexCer 17:3;2O/34:7

C57H93NO8 (919.6900818)

HexCer 21:2;2O/30:8

C57H93NO8 (919.6900818)

HexCer 15:2;2O/36:8

C57H93NO8 (919.6900818)

HexCer 15:1;2O/36:9

C57H93NO8 (919.6900818)

HexCer 17:2;2O/34:8

C57H93NO8 (919.6900818)

HexCer 19:3;2O/32:7

C57H93NO8 (919.6900818)

HexCer 13:1;2O/38:9

C57H93NO8 (919.6900818)

HexCer 19:2;2O/32:8

C57H93NO8 (919.6900818)

HexCer 21:3;2O/30:7

C57H93NO8 (919.6900818)

SHexCer 21:1;2O/22:1;O

C49H93NO12S (919.6418138)

SHexCer 25:2;2O/18:0;O

C49H93NO12S (919.6418138)

HexCer 13:0;2O/38:10

C57H93NO8 (919.6900818)

SHexCer 22:1;2O/21:1;O

C49H93NO12S (919.6418138)

SHexCer 24:2;2O/19:0;O

C49H93NO12S (919.6418138)

SHexCer 20:2;2O/23:0;O

C49H93NO12S (919.6418138)

HexCer 11:0;2O/40:10

C57H93NO8 (919.6900818)

SHexCer 25:0;2O/18:2;O

C49H93NO12S (919.6418138)

SHexCer 21:0;2O/22:2;O

C49H93NO12S (919.6418138)

SHexCer 23:0;2O/20:2;O

C49H93NO12S (919.6418138)

SHexCer 19:0;2O/24:2;O

C49H93NO12S (919.6418138)

SHexCer 20:1;2O/23:1;O

C49H93NO12S (919.6418138)

SHexCer 18:1;2O/25:1;O

C49H93NO12S (919.6418138)

HexCer 15:0;2O/36:10

C57H93NO8 (919.6900818)

SHexCer 26:2;2O/17:0;O

C49H93NO12S (919.6418138)

SHexCer 22:2;2O/21:0;O

C49H93NO12S (919.6418138)

SHexCer 17:2;2O/26:0;O

C49H93NO12S (919.6418138)

SHexCer 17:0;2O/26:2;O

C49H93NO12S (919.6418138)

SHexCer 25:1;2O/18:1;O

C49H93NO12S (919.6418138)

SHexCer 23:1;2O/20:1;O

C49H93NO12S (919.6418138)

SHexCer 18:2;2O/25:0;O

C49H93NO12S (919.6418138)

SHexCer 24:1;2O/19:1;O

C49H93NO12S (919.6418138)

SHexCer 17:1;2O/26:1;O

C49H93NO12S (919.6418138)

SHexCer 21:2;2O/22:0;O

C49H93NO12S (919.6418138)

SHexCer 19:1;2O/24:1;O

C49H93NO12S (919.6418138)

SHexCer 19:2;2O/24:0;O

C49H93NO12S (919.6418138)

SHexCer 23:2;2O/20:0;O

C49H93NO12S (919.6418138)

2-[3-nonanoyloxy-2-[(11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-octatriaconta-11,14,17,20,23,26,29,32,35-nonaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C57H93NO8 (919.6900818)

Lnape 26:6/N-24:6

C55H86NO8P (919.6090726)

Lnaps 22:2/N-24:4

C52H90NO10P (919.6302009999999)

Lnaps 26:5/N-20:1

C52H90NO10P (919.6302009999999)

Lnaps 26:1/N-20:5

C52H90NO10P (919.6302009999999)

Lnape 26:7/N-24:5

C55H86NO8P (919.6090726)

Lnaps 20:3/N-26:3

C52H90NO10P (919.6302009999999)

Lnape 23:0/N-26:5

C54H98NO8P (919.7029678)

Lnaps 22:4/N-24:2

C52H90NO10P (919.6302009999999)

Lnaps 22:5/N-24:1

C52H90NO10P (919.6302009999999)

Lnaps 24:1/N-22:5

C52H90NO10P (919.6302009999999)

Lnape 26:5/N-23:0

C54H98NO8P (919.7029678)

Lnaps 22:0/N-24:6

C52H90NO10P (919.6302009999999)

Lnape 24:7/N-26:5

C55H86NO8P (919.6090726)

Lnaps 22:6/N-24:0

C52H90NO10P (919.6302009999999)

Lnaps 22:3/N-24:3

C52H90NO10P (919.6302009999999)

Lnaps 24:6/N-22:0

C52H90NO10P (919.6302009999999)

Lnape 22:5/N-27:0

C54H98NO8P (919.7029678)

Lnape 27:0/N-22:5

C54H98NO8P (919.7029678)

Lnape 24:5/N-26:7

C55H86NO8P (919.6090726)

Lnaps 20:2/N-26:4

C52H90NO10P (919.6302009999999)

Lnaps 24:5/N-22:1

C52H90NO10P (919.6302009999999)

Lnaps 22:1/N-24:5

C52H90NO10P (919.6302009999999)

Lnaps 26:6/N-20:0

C52H90NO10P (919.6302009999999)

Lnape 25:0/N-24:5

C54H98NO8P (919.7029678)

Lnaps 20:1/N-26:5

C52H90NO10P (919.6302009999999)

Lnape 26:5/N-24:7

C55H86NO8P (919.6090726)

Lnape 24:6/N-26:6

C55H86NO8P (919.6090726)

Lnaps 20:0/N-26:6

C52H90NO10P (919.6302009999999)

Lnaps 24:2/N-22:4

C52H90NO10P (919.6302009999999)

Lnaps 24:3/N-22:3

C52H90NO10P (919.6302009999999)

Lnaps 26:3/N-20:3

C52H90NO10P (919.6302009999999)

Lnaps 26:2/N-20:4

C52H90NO10P (919.6302009999999)

Lnape 24:5/N-25:0

C54H98NO8P (919.7029678)

Lnaps 24:0/N-22:6

C52H90NO10P (919.6302009999999)

Lnaps 24:4/N-22:2

C52H90NO10P (919.6302009999999)

Lnaps 20:4/N-26:2

C52H90NO10P (919.6302009999999)

Lnaps 20:5/N-26:1

C52H90NO10P (919.6302009999999)

Lnaps 26:4/N-20:2

C52H90NO10P (919.6302009999999)

2-[3-[(Z)-heptadec-9-enoyl]oxy-2-[(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-6,9,12,15,18,21,24,27-octaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C57H93NO8 (919.6900818)

2-[2-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-5,8,11,14,17,20,23,26,29-nonaenoyl]oxy-3-pentadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C57H93NO8 (919.6900818)

2-[2-[(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-8,11,14,17,20,23,26,29-octaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C57H93NO8 (919.6900818)

2-[2-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenoyl]oxy-3-tridecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C57H93NO8 (919.6900818)

[3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]-2-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C56H90NO7P (919.645456)

2-[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-[(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-9,12,15,18,21,24,27-heptaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C57H93NO8 (919.6900818)

2-[3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-2-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C57H93NO8 (919.6900818)

2-[2-[(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenoyl]oxy-3-undecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C57H93NO8 (919.6900818)

2-[2-[(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-10,13,16,19,22,25,28,31-octaenoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C57H93NO8 (919.6900818)

2-[3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-2-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C57H93NO8 (919.6900818)

PI-Cer 25:1;2O/18:1;O

C49H94NO12P (919.6513293999999)

PI-Cer 26:2;2O/17:0;O

C49H94NO12P (919.6513293999999)

PI-Cer 24:1;2O/19:1;O

C49H94NO12P (919.6513293999999)

PI-Cer 23:0;2O/20:2;O

C49H94NO12P (919.6513293999999)

PI-Cer 22:1;2O/21:1;O

C49H94NO12P (919.6513293999999)

PI-Cer 17:1;2O/26:1;O

C49H94NO12P (919.6513293999999)

PI-Cer 25:0;2O/18:2;O

C49H94NO12P (919.6513293999999)

PI-Cer 19:0;2O/24:2;O

C49H94NO12P (919.6513293999999)

PI-Cer 17:2;2O/26:0;O

C49H94NO12P (919.6513293999999)

PI-Cer 23:1;2O/20:1;O

C49H94NO12P (919.6513293999999)

PI-Cer 18:2;2O/25:0;O

C49H94NO12P (919.6513293999999)

PI-Cer 20:1;2O/23:1;O

C49H94NO12P (919.6513293999999)

PI-Cer 23:2;2O/20:0;O

C49H94NO12P (919.6513293999999)

PI-Cer 18:1;2O/25:1;O

C49H94NO12P (919.6513293999999)

PI-Cer 21:1;2O/22:1;O

C49H94NO12P (919.6513293999999)

PI-Cer 24:2;2O/19:0;O

C49H94NO12P (919.6513293999999)

PI-Cer 19:1;2O/24:1;O

C49H94NO12P (919.6513293999999)

PI-Cer 19:2;2O/24:0;O

C49H94NO12P (919.6513293999999)

PI-Cer 20:2;2O/23:0;O

C49H94NO12P (919.6513293999999)

PI-Cer 22:2;2O/21:0;O

C49H94NO12P (919.6513293999999)

PI-Cer 21:2;2O/22:0;O

C49H94NO12P (919.6513293999999)

PI-Cer 17:0;2O/26:2;O

C49H94NO12P (919.6513293999999)

PI-Cer 25:2;2O/18:0;O

C49H94NO12P (919.6513293999999)

PI-Cer 21:0;2O/22:2;O

C49H94NO12P (919.6513293999999)

2-amino-3-[[2-henicosanoyloxy-3-[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C53H94NO9P (919.6665843999999)

2-amino-3-[[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-2-pentacosanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C53H94NO9P (919.6665843999999)

2-amino-3-[[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-pentacosoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C53H94NO9P (919.6665843999999)

2-amino-3-[hydroxy-[3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]-2-tricosanoyloxypropoxy]phosphoryl]oxypropanoic acid

C53H94NO9P (919.6665843999999)

2-amino-3-[[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C53H94NO9P (919.6665843999999)

[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C56H90NO7P (919.645456)

[3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]-2-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C56H90NO7P (919.645456)

2-amino-3-[[2-[(Z)-henicos-11-enoyl]oxy-3-[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C53H94NO9P (919.6665843999999)

[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C56H90NO7P (919.645456)

2-amino-3-[[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C53H94NO9P (919.6665843999999)

2-amino-3-[[3-henicosoxy-2-[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C53H94NO9P (919.6665843999999)

2-amino-3-[[3-[(Z)-henicos-11-enoxy]-2-[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C53H94NO9P (919.6665843999999)

2-amino-3-[hydroxy-[2-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxy-3-tricosoxypropoxy]phosphoryl]oxypropanoic acid

C53H94NO9P (919.6665843999999)

[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C56H90NO7P (919.645456)

[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-2-[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C56H90NO7P (919.645456)

[3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoxy]-2-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C56H90NO7P (919.645456)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (19Z,22Z,25Z,28Z,31Z)-tetratriaconta-19,22,25,28,31-pentaenoate

C54H98NO8P (919.7029678)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (17Z,20Z,23Z,26Z,29Z)-dotriaconta-17,20,23,26,29-pentaenoate

C54H98NO8P (919.7029678)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxypropyl] pentacosanoate

C54H98NO8P (919.7029678)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecanoyloxypropan-2-yl] (15Z,18Z,21Z,24Z,27Z)-triaconta-15,18,21,24,27-pentaenoate

C54H98NO8P (919.7029678)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropyl] hentriacontanoate

C54H98NO8P (919.7029678)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-5,8,11,14,17,20,23,26,29-nonaenoate

C55H86NO8P (919.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoate

C55H86NO8P (919.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenoate

C55H86NO8P (919.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate

C54H98NO8P (919.7029678)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tricosanoyloxypropan-2-yl] (11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoate

C54H98NO8P (919.7029678)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropan-2-yl] (18Z,21Z,24Z)-dotriaconta-18,21,24-trienoate

C54H98NO8P (919.7029678)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropan-2-yl] (14Z,17Z,20Z)-octacosa-14,17,20-trienoate

C54H98NO8P (919.7029678)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxypropan-2-yl] (10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoate

C55H86NO8P (919.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxypropan-2-yl] (8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoate

C55H86NO8P (919.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (23Z,26Z,29Z,32Z,35Z)-octatriaconta-23,26,29,32,35-pentaenoate

C54H98NO8P (919.7029678)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoyl]oxypropan-2-yl] (16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoate

C54H98NO8P (919.7029678)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoyl]oxypropan-2-yl] (20Z,23Z,26Z,29Z)-dotriaconta-20,23,26,29-tetraenoate

C54H98NO8P (919.7029678)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (21Z,24Z,27Z,30Z,33Z)-hexatriaconta-21,24,27,30,33-pentaenoate

C54H98NO8P (919.7029678)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropan-2-yl] (16Z,19Z,22Z)-triaconta-16,19,22-trienoate

C54H98NO8P (919.7029678)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropan-2-yl] (8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-8,11,14,17,20,23,26,29-octaenoate

C55H86NO8P (919.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoyl]oxypropan-2-yl] (18Z,21Z,24Z,27Z)-triaconta-18,21,24,27-tetraenoate

C54H98NO8P (919.7029678)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropyl] nonacosanoate

C54H98NO8P (919.7029678)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (22Z,25Z,28Z,31Z)-tetratriaconta-22,25,28,31-tetraenoate

C54H98NO8P (919.7029678)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoate

C55H86NO8P (919.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-henicosanoyloxypropan-2-yl] (13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoate

C54H98NO8P (919.7029678)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropan-2-yl] (9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-9,12,15,18,21,24,27-heptaenoate

C55H86NO8P (919.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropan-2-yl] (6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-6,9,12,15,18,21,24,27-octaenoate

C55H86NO8P (919.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropan-2-yl] (11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-11,14,17,20,23,26,29-heptaenoate

C55H86NO8P (919.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropan-2-yl] (10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-10,13,16,19,22,25,28,31-octaenoate

C55H86NO8P (919.6090726)

AHexCer (O-16:5)17:1;2O/16:5;O

C55H85NO10 (919.617315)

SHexCer 44:1;2O

C50H97NO11S (919.6781972)

SHexCer 21:1;2O/23:0

C50H97NO11S (919.6781972)

SHexCer 22:0;2O/22:1

C50H97NO11S (919.6781972)

SHexCer 24:1;2O/20:0

C50H97NO11S (919.6781972)

SHexCer 22:1;2O/22:0

C50H97NO11S (919.6781972)

SHexCer 23:1;2O/21:0

C50H97NO11S (919.6781972)

SHexCer 20:0;2O/24:1

C50H97NO11S (919.6781972)

SHexCer 16:0;2O/28:1

C50H97NO11S (919.6781972)

SHexCer 24:0;2O/20:1

C50H97NO11S (919.6781972)

SHexCer 27:1;2O/17:0

C50H97NO11S (919.6781972)

SHexCer 18:0;2O/26:1

C50H97NO11S (919.6781972)

SHexCer 25:1;2O/19:0

C50H97NO11S (919.6781972)

SHexCer 19:1;2O/25:0

C50H97NO11S (919.6781972)

SHexCer 25:0;2O/19:1

C50H97NO11S (919.6781972)

SHexCer 30:1;2O/14:0

C50H97NO11S (919.6781972)

SHexCer 17:0;2O/27:1

C50H97NO11S (919.6781972)

SHexCer 19:0;2O/25:1

C50H97NO11S (919.6781972)

SHexCer 23:0;2O/21:1

C50H97NO11S (919.6781972)

SHexCer 15:0;2O/29:1

C50H97NO11S (919.6781972)

SHexCer 16:1;2O/28:0

C50H97NO11S (919.6781972)

SHexCer 26:0;2O/18:1

C50H97NO11S (919.6781972)

SHexCer 30:0;2O/14:1

C50H97NO11S (919.6781972)

SHexCer 21:0;2O/23:1

C50H97NO11S (919.6781972)

SHexCer 14:1;2O/30:0

C50H97NO11S (919.6781972)

SHexCer 28:1;2O/16:0

C50H97NO11S (919.6781972)

SHexCer 20:1;2O/24:0

C50H97NO11S (919.6781972)

SHexCer 15:1;2O/29:0

C50H97NO11S (919.6781972)

SHexCer 26:1;2O/18:0

C50H97NO11S (919.6781972)

SHexCer 28:0;2O/16:1

C50H97NO11S (919.6781972)

SHexCer 29:0;2O/15:1

C50H97NO11S (919.6781972)

SHexCer 29:1;2O/15:0

C50H97NO11S (919.6781972)

SHexCer 18:1;2O/26:0

C50H97NO11S (919.6781972)

SHexCer 17:1;2O/27:0

C50H97NO11S (919.6781972)

Hex2Cer 18:0;2O/20:0

C50H97NO13 (919.6959552)

Hex2Cer 16:0;2O/22:0

C50H97NO13 (919.6959552)

Hex2Cer 19:0;2O/19:0

C50H97NO13 (919.6959552)

Hex2Cer 20:0;2O/18:0

C50H97NO13 (919.6959552)

Hex2Cer 17:0;2O/21:0

C50H97NO13 (919.6959552)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-dotetraconta-6,9,12,15,18,21,24,27,30,33,36,39-dodecaenoate

C55H86NO8P (919.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (25Z,28Z,31Z,34Z,37Z)-tetraconta-25,28,31,34,37-pentaenoate

C54H98NO8P (919.7029678)

[3-octanoyloxy-2-[(23Z,26Z,29Z,32Z,35Z)-octatriaconta-23,26,29,32,35-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

2-amino-3-[[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(Z)-tetracos-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

2-amino-3-[[3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

2-amino-3-[[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-tetracosanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

2-amino-3-[[3-[(Z)-hexacos-15-enoyl]oxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

2-amino-3-[[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxypropyl] heptacosanoate

C54H98NO8P (919.7029678)

2-amino-3-[[3-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

[2-[(13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[3-[(Z)-hexadec-9-enoyl]oxy-2-[(18Z,21Z,24Z,27Z)-triaconta-18,21,24,27-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[2-[(17Z,20Z,23Z,26Z,29Z)-dotriaconta-17,20,23,26,29-pentaenoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[3-octacosanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[3-[(Z)-octacos-17-enoyl]oxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-[(19Z,22Z)-triaconta-19,22-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[2-[(16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[3-decanoyloxy-2-[(21Z,24Z,27Z,30Z,33Z)-hexatriaconta-21,24,27,30,33-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-[(16Z,19Z,22Z)-triaconta-16,19,22-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[3-[(17Z,20Z)-octacosa-17,20-dienoyl]oxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[2-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[3-dodecanoyloxy-2-[(19Z,22Z,25Z,28Z,31Z)-tetratriaconta-19,22,25,28,31-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(Z)-triacont-19-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[3-docosanoyloxy-2-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[2-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[3-hexadecanoyloxy-2-[(15Z,18Z,21Z,24Z,27Z)-triaconta-15,18,21,24,27-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[2-[(20Z,23Z,26Z,29Z)-dotriaconta-20,23,26,29-tetraenoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[2-[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-3-icosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-[(Z)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[3-[(Z)-docos-13-enoyl]oxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[3-hexacosanoyloxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

2-amino-3-[[2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[3-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetracosan-2-yl]tetradecanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxynonacosan-2-yl]nonanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosan-2-yl]hexadecanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetratriacontan-2-yl]butanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytricosan-2-yl]pentadecanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhentriacontan-2-yl]heptanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctacosan-2-yl]decanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxypentacosan-2-yl]tridecanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyundecan-2-yl]heptacosanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydodecan-2-yl]hexacosanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxypentadecan-2-yl]tricosanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhenicosan-2-yl]heptadecanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyheptacosan-2-yl]undecanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexacosan-2-yl]dodecanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytridecan-2-yl]pentacosanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydecan-2-yl]octacosanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxynonan-2-yl]nonacosanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctan-2-yl]triacontanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxypentatriacontan-2-yl]propanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydotriacontan-2-yl]hexanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytritriacontan-2-yl]pentanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradecan-2-yl]tetracosanamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexatriacontan-2-yl]acetamide

C50H97NO13 (919.6959552)

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriacontan-2-yl]octanamide

C50H97NO13 (919.6959552)

(2S)-2-amino-3-[[(2S)-2-[(E)-hexacos-5-enoyl]oxy-3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

(2S)-2-amino-3-[[(2S)-2-[(5E,9E)-hexacosa-5,9-dienoyl]oxy-3-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

[(2S)-3-[(E)-hexacos-5-enoyl]oxy-2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[(2R)-2-[(E)-docos-13-enoyl]oxy-3-[(5E,8E,11E,14E)-tetracosa-5,8,11,14-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

(2S)-2-amino-3-[[(2R)-3-[(13E,16E)-docosa-13,16-dienoyl]oxy-2-[(5E,8E,11E,14E)-tetracosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

(2S)-2-amino-3-[[(2R)-2-[(4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoyl]oxy-3-[(E)-tetracos-15-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

(2S)-2-amino-3-[[(2R)-2-[(13E,16E)-docosa-13,16-dienoyl]oxy-3-[(5E,8E,11E,14E)-tetracosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

(2S)-2-amino-3-[[(2R)-3-[(4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoyl]oxy-2-[(E)-tetracos-15-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

[(2R)-2-[(5E,9E)-hexacosa-5,9-dienoyl]oxy-3-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[(2S)-3-[(5E,9E)-hexacosa-5,9-dienoyl]oxy-2-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[(2R)-3-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[(2R)-3-[(E)-docos-13-enoyl]oxy-2-[(5E,8E,11E,14E)-tetracosa-5,8,11,14-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[(2S)-3-hexacosanoyloxy-2-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[(2S)-3-[(5E,9E)-hexacosa-5,9-dienoyl]oxy-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

(2S)-2-amino-3-[[(2R)-2-[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-tetracosanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

[(2R)-2-[(E)-hexacos-5-enoyl]oxy-3-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

(2S)-2-amino-3-[[(2S)-2-[(5E,9E)-hexacosa-5,9-dienoyl]oxy-3-[(7E,10E,13E,16E)-icosa-7,10,13,16-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

(2S)-2-amino-3-[[(2R)-2-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(E)-tetracos-15-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

(2S)-2-amino-3-[[(2R)-3-[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-tetracosanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

[(2R)-3-[(7E,10E,13E,16E)-docosa-7,10,13,16-tetraenoyl]oxy-2-[(E)-tetracos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[(2S)-3-[(E)-hexacos-5-enoyl]oxy-2-[(7E,10E,13E,16E)-icosa-7,10,13,16-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

(2S)-2-amino-3-[[(2R)-3-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-[(E)-tetracos-15-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C52H90NO10P (919.6302009999999)

[(2R)-2-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[(2R)-2-[(E)-hexacos-5-enoyl]oxy-3-[(7E,10E,13E,16E)-icosa-7,10,13,16-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[(2R)-2-[(7E,10E,13E,16E)-docosa-7,10,13,16-tetraenoyl]oxy-3-[(E)-tetracos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[(2R)-2-[(5E,9E)-hexacosa-5,9-dienoyl]oxy-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[(2R)-3-[(4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoyl]oxy-2-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[(2R)-2-[(4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoyl]oxy-3-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

[(2R)-2-hexacosanoyloxy-3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C54H98NO8P (919.7029678)

2-[[(E)-2-[[(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-dotetraconta-9,12,15,18,21,24,27,30,33,36,39-undecaenoyl]amino]-3-hydroxynon-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C56H92N2O6P+ (919.6692642)

2-[[(4E,8E,12E)-2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-5,8,11,14,17,20,23,26,29-nonaenoyl]amino]-3-hydroxynonadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C56H92N2O6P+ (919.6692642)

2-[[2-[[(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-dotetraconta-6,9,12,15,18,21,24,27,30,33,36,39-dodecaenoyl]amino]-3-hydroxynonoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C56H92N2O6P+ (919.6692642)

2-[hydroxy-[(E)-3-hydroxy-2-[[(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenoyl]amino]undec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C56H92N2O6P+ (919.6692642)

2-[[(4E,8E)-2-[[(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenoyl]amino]-3-hydroxypentadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C56H92N2O6P+ (919.6692642)

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenoyl]amino]heptadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C56H92N2O6P+ (919.6692642)

2-[[(4E,8E,12E)-2-[[(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenoyl]amino]-3-hydroxypentadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C56H92N2O6P+ (919.6692642)

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-octatriaconta-8,11,14,17,20,23,26,29,32,35-decaenoyl]amino]trideca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C56H92N2O6P+ (919.6692642)

phosphatidylinositol 40:1(1-)

C49H92O13P (919.6275211999999)

A 1-phosphatidyl-1D-myo-inositol(1-) in which the acyl groups at C-1 and C-2 contain 40 carbons in total and 1 double bond.

PE(49:5)

C54H98NO8P (919.7029678)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

DGCC 45:11;O2

C55H85NO10 (919.617315)

DGCC 46:10;O

C56H89NO9 (919.6536984)

DGCC 47:9

C57H93NO8 (919.6900818)

DGTS 46:10;O2

C56H89NO9 (919.6536984)

DGTS 47:9;O

C57H93NO8 (919.6900818)

PC 22:1/22:6;O2

C52H90NO10P (919.6302009999999)

PC 22:2/22:5;O2

C52H90NO10P (919.6302009999999)

PC 44:7;O2

C52H90NO10P (919.6302009999999)

PC 20:3_26:2

C54H98NO8P (919.7029678)

PC 20:4_26:1

C54H98NO8P (919.7029678)

PC 20:5_26:0

C54H98NO8P (919.7029678)

PC 22:1_24:4

C54H98NO8P (919.7029678)

PC 22:4_24:1

C54H98NO8P (919.7029678)

PC 22:5_24:0

C54H98NO8P (919.7029678)

PC 46:5

C54H98NO8P (919.7029678)

LNAPE 48:6;O

C53H94NO9P (919.6665843999999)

LNAPE 49:5

C54H98NO8P (919.7029678)

LNAPE 50:12

C55H86NO8P (919.6090726)

PE 20:5_29:0

C54H98NO8P (919.7029678)

PE 22:5_27:0

C54H98NO8P (919.7029678)

PE 49:5

C54H98NO8P (919.7029678)

PE 50:12

C55H86NO8P (919.6090726)

LNAPS 44:0;O

C50H98NO11P (919.6877128)

LNAPS 46:6

C52H90NO10P (919.6302009999999)

PS 20:4_26:2

C52H90NO10P (919.6302009999999)

PS 20:5_26:1

C52H90NO10P (919.6302009999999)

PS 22:2_24:4

C52H90NO10P (919.6302009999999)

PS 22:5_24:1

C52H90NO10P (919.6302009999999)

PS 22:6_24:0

C52H90NO10P (919.6302009999999)

PS 46:6

C52H90NO10P (919.6302009999999)

Hex2Cer 14:0;O2/24:0

C50H97NO13 (919.6959552)

Hex2Cer 14:1;O2/23:0;O

C49H93NO14 (919.6595718)

Hex2Cer 15:0;O2/22:1;O

C49H93NO14 (919.6595718)

Hex2Cer 15:0;O2/23:0

C50H97NO13 (919.6959552)

Hex2Cer 15:1;O2/22:0;O

C49H93NO14 (919.6595718)

Hex2Cer 16:0;O2/22:0

C50H97NO13 (919.6959552)

Hex2Cer 16:1;O2/21:0;O

C49H93NO14 (919.6595718)

Hex2Cer 17:0;O2/20:1;O

C49H93NO14 (919.6595718)

Hex2Cer 17:0;O2/21:0

C50H97NO13 (919.6959552)

Hex2Cer 17:1;O2/20:0;O

C49H93NO14 (919.6595718)

Hex2Cer 18:0;O2/20:0

C50H97NO13 (919.6959552)

Hex2Cer 18:1;O2/19:0;O

C49H93NO14 (919.6595718)

Hex2Cer 19:0;O2/18:1;O

C49H93NO14 (919.6595718)

Hex2Cer 19:0;O2/19:0

C50H97NO13 (919.6959552)

Hex2Cer 19:1;O2/18:0;O

C49H93NO14 (919.6595718)

Hex2Cer 20:0;O2/18:0

C50H97NO13 (919.6959552)

Hex2Cer 20:1;O2/17:0;O

C49H93NO14 (919.6595718)

Hex2Cer 21:0;O2/17:0

C50H97NO13 (919.6959552)

Hex2Cer 21:1;O2/16:0;O

C49H93NO14 (919.6595718)

Hex2Cer 22:0;O2/16:0

C50H97NO13 (919.6959552)

Hex2Cer 22:1;O2/15:0;O

C49H93NO14 (919.6595718)

Hex2Cer 36:2;O4

C48H89NO15 (919.6231884)

Hex2Cer 37:1;O2;O

C49H93NO14 (919.6595718)

LacCer 14:0;O2/24:0

C50H97NO13 (919.6959552)

LacCer 14:1;O2/23:0;O

C49H93NO14 (919.6595718)

LacCer 15:0;O2/22:1;O

C49H93NO14 (919.6595718)

LacCer 15:0;O2/23:0

C50H97NO13 (919.6959552)

LacCer 15:1;O2/22:0;O

C49H93NO14 (919.6595718)

LacCer 16:0;O2/22:0

C50H97NO13 (919.6959552)

LacCer 16:1;O2/21:0;O

C49H93NO14 (919.6595718)

LacCer 17:0;O2/20:1;O

C49H93NO14 (919.6595718)

LacCer 17:0;O2/21:0

C50H97NO13 (919.6959552)

LacCer 17:1;O2/20:0;O

C49H93NO14 (919.6595718)

LacCer 18:0;O2/20:0

C50H97NO13 (919.6959552)

LacCer 18:1;O2/19:0;O

C49H93NO14 (919.6595718)

LacCer 19:0;O2/18:1;O

C49H93NO14 (919.6595718)

LacCer 19:0;O2/19:0

C50H97NO13 (919.6959552)

LacCer 19:1;O2/18:0;O

C49H93NO14 (919.6595718)

LacCer 20:0;O2/18:0

C50H97NO13 (919.6959552)

LacCer 20:1;O2/17:0;O

C49H93NO14 (919.6595718)

LacCer 21:0;O2/17:0

C50H97NO13 (919.6959552)

LacCer 21:1;O2/16:0;O

C49H93NO14 (919.6595718)

LacCer 22:0;O2/16:0

C50H97NO13 (919.6959552)

LacCer 22:1;O2/15:0;O

C49H93NO14 (919.6595718)

LacCer 37:1;O2;O

C49H93NO14 (919.6595718)

LacCer 38:0;O2

C50H97NO13 (919.6959552)

SHexCer 43:2;O3

C49H93NO12S (919.6418138)

SHexCer 44:1;O2

C50H97NO11S (919.6781972)

IPC 14:1;O2/30:0

C50H98NO11P (919.6877128)

IPC 15:1;O2/29:0

C50H98NO11P (919.6877128)

IPC 16:1;O2/28:0

C50H98NO11P (919.6877128)

IPC 17:0;O2/26:2;O

C49H94NO12P (919.6513293999999)

IPC 17:1;O2/27:0

C50H98NO11P (919.6877128)

IPC 17:2;O2/26:0;O

C49H94NO12P (919.6513293999999)

IPC 18:0;O2/26:1

C50H98NO11P (919.6877128)

IPC 18:1;O2/26:0

C50H98NO11P (919.6877128)

IPC 18:2;O2/25:0;O

C49H94NO12P (919.6513293999999)

IPC 19:1;O2/24:1;O

C49H94NO12P (919.6513293999999)

IPC 19:1;O2/25:0

C50H98NO11P (919.6877128)

IPC 19:2;O2/24:0;O

C49H94NO12P (919.6513293999999)

IPC 20:0;O2/24:1

C50H98NO11P (919.6877128)

IPC 20:1;O2/24:0

C50H98NO11P (919.6877128)

IPC 20:2;O2/23:0;O

C49H94NO12P (919.6513293999999)

IPC 21:1;O2/22:1;O

C49H94NO12P (919.6513293999999)

IPC 21:1;O2/23:0

C50H98NO11P (919.6877128)

IPC 21:2;O2/22:0;O

C49H94NO12P (919.6513293999999)

IPC 22:0;O2/22:1

C50H98NO11P (919.6877128)

IPC 22:1;O2/22:0

C50H98NO11P (919.6877128)

IPC 22:2;O2/21:0;O

C49H94NO12P (919.6513293999999)

IPC 43:2;O2;O

C49H94NO12P (919.6513293999999)

IPC 44:1;O2

C50H98NO11P (919.6877128)

TDCAE 30:7

C56H89NO7S (919.6359404)

ST(44:1)

C50H97NO11S (919.6781972)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved